能特科技(002102) - 2025 Q2 - 季度业绩预告

Hubei Net Technology Co., Ltd. 2025 Semi-Annual Performance Forecast Current Period Performance Forecast The company expects to turn losses into profits in the first half of 2025, with net profit attributable to shareholders estimated between 330 million yuan and 380 million yuan, representing a year-on-year growth of 480.15% to 568.05% Performance Forecast Period This performance forecast covers the period from January 1, 2025, to June 30, 2025 - The performance forecast covers the first half of 2025, specifically from January 1, 2025, to June 30, 2025[3] Performance Forecast Details During the reporting period, the company expects significant growth in both net profit attributable to shareholders and non-recurring net profit, with basic earnings per share increasing from 0.0216 yuan/share in the same period last year to 0.1253 yuan/share to 0.1443 yuan/share Key Data from 2025 Semi-Annual Performance Forecast | Item | Current Reporting Period | Prior Year Same Period | | :--- | :--- | :--- | | Net Profit Attributable to Shareholders of Listed Company | Profit: 330.00 million yuan ~ 380.00 million yuan | Profit: 56.88 million yuan | | | Year-on-year growth: 480.15% - 568.05% | | | Net Profit After Deducting Non-Recurring Gains and Losses | Profit: 400.00 million yuan ~ 450.00 million yuan | Profit: 47.82 million yuan | | Basic Earnings Per Share | Profit: 0.1253 yuan/share ~ 0.1443 yuan/share | Profit: 0.0216 yuan/share | Communication with Accounting Firm The company explicitly states that the financial data in this performance forecast are preliminary estimates by the finance department and have not yet been audited by a certified public accountant - The data in this performance forecast are preliminary estimates by the company's finance department and have not been audited by a certified public accountant[4] Explanation of Performance Change The significant performance growth is primarily driven by the wholly-owned subsidiary, Net Technology Co., Ltd., whose strong performance in Vitamin E and pharmaceutical intermediate businesses is expected to contribute no less than 440 million yuan in profit to the company - Performance growth is primarily attributed to the Vitamin E and pharmaceutical intermediate businesses of the wholly-owned subsidiary, Net Technology Co., Ltd., which are expected to contribute no less than 440 million yuan in profit[5] Risk Warning The company reminds investors that this forecast is a preliminary estimate, and the final accurate financial data will be subject to the company's officially disclosed 2025 semi-annual report, advising investors to be aware of investment risks - The company advises that this performance forecast is a preliminary estimate, and the final data will be based on the 2025 semi-annual report, urging investors to make cautious decisions[6]